
Dapagliflozin, a Novel SGLT2 Inhibitor, Induces Dose-Dependent Glucosuria in Healthy Subjects
Komoroski, B, Vachharajani, N, Boulton, D, Kornhauser, D, Geraldes, M, Li, L, Pfister, MVolume:
85
Année:
2009
Langue:
english
Pages:
7
DOI:
10.1038/clpt.2008.251
Fichier:
PDF, 1.82 MB
english, 2009